Akari COO On Progress Of Lead Rare Disease Drug
Executive Summary
Clive Richardson, chief operation officer of Akari Therapeutics, speaks to Scrip at the BIO-Europe partnering meeting in Berlin, Germany, about the company's pipeline of potential therapies for orphan inflammatory diseases.